StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.37−0.04 (-0.79%)

Close on Nov 17, 2026Market cap $1.36BP/E 43.7Yield –

Alvotech cash

Cash and short-term investments held at the end of each period.

Alvotech's cash was $142.75M at Jun 30, 2026. For fiscal 2025 it was $172.36M, up 235.1% from the year before. The highest annual figure on record is $172.36M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$172.36M+235.1%
FY2024Dec 31, 2024$51.43M+360.9%
FY2023Dec 31, 2023$11.16M-83.2%
FY2022Dec 31, 2022$66.43M+278.4%
FY2021Dec 31, 2021$17.56M-44.6%
FY2020Dec 31, 2020$31.69M-53.0%
FY2019Dec 31, 2019$67.40M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$142.75M+1204.4%
Q4 FY2025Dec 31, 2025$172.36M+1444.9%
Q2 FY2025Jun 30, 2025$151.45M+150.5%
Q4 FY2024Dec 31, 2024$51.43M-22.6%
Q2 FY2024Jun 30, 2024$10.94M-91.5%
Q4 FY2023Dec 31, 2023$11.16M-36.4%
Q2 FY2023Jun 30, 2023$60.47M+90.8%
Q4 FY2022Dec 31, 2022$66.43M-1.4%
Q2 FY2022Jun 30, 2022$128.44M–
Q4 FY2021Dec 31, 2021$17.56M–
Q4 FY2020Dec 31, 2020$31.69M–
Q4 FY2019Dec 31, 2019$67.40M–

More Alvotech figures

See a number that looks wrong?